Eva Castellano

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Baboon endogenous retrovirus (ERV) envelope pseudotyped lentiviral vectors outperform human ERV lentivectors for transduction of T, B, NK and HSPCs.

Baboon endogenous retrovirus (ERV) envelope pseudotyped lentiviral vectors outperform human ERV lentivectors for transduction of T, B, NK and HSPCs.

Journal: Gene therapy
Published: July 15, 2025

GMP-compliant manufacturing of allogeneic peripheral blood CAR-NK cells for the treatment of acute myeloid leukemia.

GMP-compliant manufacturing of allogeneic peripheral blood CAR-NK cells for the treatment of acute myeloid leukemia.

Journal: Cytotherapy
Published: May 09, 2025

The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma.

The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 06, 2025

Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma.

Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma.

Journal: Communications biology
Published: July 03, 2023

CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients.

CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients.

Journal: Frontiers in immunology
Published: June 16, 2022

Overcoming tumor resistance mechanisms in CAR-NK cell therapy.

Overcoming tumor resistance mechanisms in CAR-NK cell therapy.

Journal: Frontiers in immunology
Published: May 26, 2022

Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9+ tumors.

Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9+ tumors.

Journal: Frontiers in immunology
Published: November 30, 2021

The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression.

The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression.

Journal: Cancers
Published: November 30, 2020

BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine.

BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine.

Journal: Cancers
Published: June 07, 2019

Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF.

Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF.

Journal: Cancer cell
Published: July 02, 2018
Showing 1-10 of 10

Last Updated: 09/26/2026